Hasten Chooses bioaccess™ to Enter the Colombian Medical Device Market and Introduce Palette Life Sciences', Germitec, and Bioderm Products

Hasten chooses bioaccess to enter the Colombian medical device market with Palette Life Sciences, Germitec, and Bioderm.

[JULY 30, 2020, ORLANDO, FL] Hasten LLC, a company specialized in enabling and accelerating the entry of new innovative products, devices, solutions, and technologies in developing countries, has chosen bioaccess™ to obtain regulatory registration and market clearance for its clients, Palette Life Sciences, Germitec, and Bioderm at INVIMA in Colombia, and help guide Hasten's market access strategy in the country.

Palette Life Sciences is a fully integrated life sciences company. Its products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. Its portfolio of available products includes Deflux® (available in the United States, Australia, Canada, Europe, Latin America, New Zealand, and Japan), Solesta® (available in the United States and Europe), and Barrigel® (available in Europe). Lead by experienced healthcare executives, Palette Life Sciences is headquartered in Stockholm, Sweden, with executive offices in Santa Barbara, California, and Dallas, Texas.

Founded in 2005, Germitec® is specialized in the high-level disinfection of ultrasound probes. The company has developed Antigermix® which replaces chemistry with photons and thus constitutes a technological breakthrough. Antigermix® is the 4th and last high-level disinfection method for medical devices, intended to replace previous generations: chemical soaking, systems using several wipes, and semi-automatic systems using hydrogen peroxide.

Headquartered in Largo, Florida, BioDerm is one of the nation’s leading manufacturers of proprietary hydrocolloid products for urinary management, securement, infection control, and skin protection. The company challenges accepted inferior standards of care by creating products that reduce infection rates, add comfort and reliability, and vastly improve quality of life. BioDerm’s subsidiary company, Wound Care Resources™ has specialized in insurance billing for patients with wounds since 2006. After becoming aware of the needs of the VAD community in 2010, WCR began billing patients’ insurance companies for surgical dressings needed for driveline exit site maintenance.

About Hasten LLC

Hasten LLC is a company specialized in negotiations in the health industry chain, enabling and accelerating the entry of new innovative products, devices, solutions, and technologies in developing countries. More information at www.humanmed.com.

About bioaccess™

bioaccess™ —a Florida-based clinical research organization (CRO) with the mission to help innovative life science companies conduct clinical research and commercialize their innovations in Colombia— will design the Libella study and will provide support services (e.g., IRB submission, logistical support, project management, statistical analysis, and study monitoring; among others). More information at www.bioaccessla.com.

###

Media Contact:

Julio G. Martinez-Clark

CEO, bioaccess™

jmclark@bioaccessla.com

+1 (954) 903-7210